药物治疗溃疡性结肠炎的信号通路研究进展

doi:10.3969/j.issn.2095-1396.2020.04.008

神经药理学报 ›› 2020, Vol. 10 ›› Issue (4): 41-50.DOI: 10.3969/j.issn.2095-1396.2020.04.008

药物治疗溃疡性结肠炎的信号通路研究进展

郭子霞，安子璇，张健美，张丹参

1 河北北方学院药学系，张家口，075000，中国
2 河北科技大学，石家庄，050018，中国

出版日期:2020-08-26 发布日期:2020-08-26
通讯作者: 张丹参，教授，博士，博士生导师；研究方向：神经药理学；E-mail：zhangds2011@126.com
作者简介:郭子霞，硕士研究生；研究方向：药理学；E-mail：2389707795@qq.com
基金资助:
河北省重点研发计划项目生物医药专项（No.20372509D）；河北省自然科学基金（No.H2020208032）；河北省高等学校科学技

术研究项目（No.ZD2020117）；河北省中医药管理局中医药科研计划项目（No.2020268）；中央财政公共卫生专项“中药资源普

查项目”（No.Z135080000022）

Research Progress of Signal Pathways in Drug Treatment of Ulcerative Colitis

GUO Zi-xia，AN Zi-xuan，ZHANG Jian-mei，ZHANG Dan-shen

1. Department of Pharmacy，Hebei North University，Zhangjiakou，075000，China
2. Hebei University of Science and Technology，Shijiazhuang，050018，China

Online:2020-08-26 Published:2020-08-26
Contact: 张丹参，教授，博士，博士生导师；研究方向：神经药理学；E-mail：zhangds2011@126.com
About author:郭子霞，硕士研究生；研究方向：药理学；E-mail：2389707795@qq.com
Supported by:
河北省重点研发计划项目生物医药专项（No.20372509D）；河北省自然科学基金（No.H2020208032）；河北省高等学校科学技
术研究项目（No.ZD2020117）；河北省中医药管理局中医药科研计划项目（No.2020268）；中央财政公共卫生专项“中药资源普
查项目”（No.Z135080000022）

摘要/Abstract

摘要：

溃疡性结肠炎（ulcerative colitis，UC）是一种受多因素共同影响的疾病，易反复发作，是世界公认的难治病之一，目前药物治疗效果不佳，所以越来越引起人们重视。该文主要综述UC 及治疗药物作用的相关信号通路，为以后新药或新机制研究提供更多参考依据，并对实验所用动物模型的造模方法进行分类评价，以期为研究者选择合适的模型提供参考。

关键词: 溃疡性结肠炎, 造模方法, 药物治疗, 信号通路

Abstract:

Ulcerative colitis （UC） is a disease affected by multiple factors and is prone to repeated attacks. It is one of the most intractable diseases recognized in the world. The effect of current drug treatment is not good，so people pay more and more attention to it. This article mainly reviews the signal pathways related to UC pathogenesis and the effects of therapeutic drugs，to provide more reference for future research on new drugs or new mechanisms，and to classify and evaluate the modeling methods of animal models used in experiments，in order to provide references for researchers to choose suitable models.

Key words: ulcerative colitis, modeling method, medication, signal pathway

中图分类号:

R574.62

郭子霞, 安子璇, 张健美, 张丹参. 药物治疗溃疡性结肠炎的信号通路研究进展[J]. 神经药理学报, 2020, 10(4): 41-50.

GUO Zi-xia, AN Zi-xuan, ZHANG Jian-mei, ZHANG Dan-shen. Research Progress of Signal Pathways in Drug Treatment of Ulcerative Colitis[J]. ACTA NEUROPHARMACOLOGICA, 2020, 10(4): 41-50.

参考文献

[1] Nitima Tatiya-Aphiradee, Waranya Chatuphonprasert, Kanokwan Jarukamjorn. Immune response and inflammatory pathway of ulcerative colitis[J]. J Basic Clin Physiol Pharmacol, 2018, 30(1): 1-10.

[2] Fernández-Clotet Agnès, Castro-Poceiro Jesús, Panés Julián. Tofacitinib for the treatment of ulcerative colitis[J] .Expert Rev Clin Immunol, 2018, 14 (11): 881-892.

[3] 衡宇, 李晰, 孙涛, 等. 葡聚糖硫酸钠自由饮用与灌胃诱导小鼠溃疡性结肠炎模型的对比研究[J].中国药师, 2017, 20(04): 603-606.

[4] 刘煜洪. 广藿香醇胃液代谢物β-广藿香烯抗胃溃疡及溃疡性结肠炎的研究[D].广州：广州中医药大学,2018.

[5] 孙晓萍, 侯丽娟, 王晓红, 等. 大鼠慢性溃疡性结肠炎模型的建立及操作规范探讨[J].天津中医药, 2012, 29(03): 270-273.

[6] 卢倩, 孙敏哲, 杜雯雯, 等. 复方蜚蠊提取物PB对异体抗原联合醋酸诱导大鼠慢性溃疡性结肠炎的作用机制[J].中国药理学通报, 2019, 35(09): 1296-1301.

[7] 王海强, 郑丽红, 朱峰, 等. 肠愈宁颗粒对大鼠溃疡性结肠炎的药效及作用机制[J].中医学报, 2019, 34(04): 754-759.

[8] Azza Abdelfattah Ali, Ekram Nemr Abd Al Haleem, Sahar Abdel-Hafeez Khaleel, et al. Protective effect of cardamonin against acetic acid-induced ulcerative colitis in rats[J]. Pharmacol Rep, 2017, 69(2): 268-275.

[9] 孙茂庆,卜平.化学刺激致溃疡性结肠炎兔模型的建立[J].海南医学院学报, 2011, 17(03): 296-298, 308.

[10] 朱磊, 沈洪, 王玖, 等. 参榆灌肠方对溃疡性结肠炎模型大鼠肠黏膜修复的影响[J].中医药导报, 2016, 22(24): 13-15, 28.

[11] 陶赟, 龚国清, 钱之玉, 等. 西红花酸对溃疡性结肠炎大鼠模型的作用及其机制研究[J].中国临床药理学与治疗学, 2013, 18(03): 263-270.

[12] Shi Xuan-zheng, John H Winston, Sushil K Sarna. Differential immune and genetic responses in rat models of Crohn's colitis and ulcerative colitis[J]. Am J Physiol Gastrointest Liver Physiol, 2011, 300(1): G41-51.

[13] 李燕舞, 巫燕莉. 慢性溃疡性结肠炎大鼠结肠黏膜异型增生模型探讨[J].现代中西医结合杂志, 2012, 21(23): 2533-2535.

[14] 张丹参, 王倩, 田慧, 等. 大黄栓制剂对两种溃疡性结肠炎模型小鼠的作用研究[J].神经药理学报, 2015, 5(01): 19-37.

[15] Adriana Estrella González-Ramírez, María Eva González-Trujano, Sandra A Orozco-Suárez, et al. Nerol alleviates pathologic markers in the oxazolone-induced colitis model.[J]. Eur J Pharmacol, 2016, 776: 81-89.

[16] Zhang Liu-hong, Cao Ning, Wang Yu-wen, et al. Improvement of Oxazolone-Induced Ulcerative Colitis in Rats Using Andrographolide[J]. Molecules, 2019, 25(1): 76.

[17] 宋晓敏, 张丹参, 庄忠宝, 等. 噁唑酮与三硝基苯磺酸联用诱导小鼠慢性溃疡性结肠炎模型[J].神经药理学报, 2016, 6(03): 17-23.

[18] 马克龙, 韩志君, 潘敏, 等. 肉桂醛对白念珠菌定植下DSS诱导的溃疡性结肠炎小鼠治疗作用及对dectin-1/TLRs/NF-κB信号通路的影响[J].中国中药杂志, 2020, 45(13): 3211-3219.

[19] 丁洁, 吴正祥, 杨九华, 等. 三硝基苯磺酸/乙醇与结肠细菌菌株诱导的实验性结肠炎模型的建立与评价[J].胃肠病学和肝病学杂志, 2011, 20(03): 263-267.

[20] 申睿, 刘苗, 朱向东, 等. 溃疡性结肠炎大鼠实验模型研究进展[J].中华中医药杂志, 2018, 33(09): 3998-4001.

[21] Christoffer Soendergaard, Fredrik Holmberg Bergenheim, Jakob Tveiten Bjerrum, et al. Targeting JAK-STAT signal transduction in IBD [J]. Pharmacol Ther, 2018, 192: 100-111.

[22] Azucena Salas, Cristian Hernandez-Rocha, Marjolijn Duijvestein, et al. JAK-STAT pathway targeting for the treatment of inflammatory bowel disease[J]. Nat Rev Gastroenterol Hepatol, 2020, 17 (6): 323-337.

[23] Núria Planell, Juan J Lozano, Rut Mora-Buch, et al. Transcriptional analysis of the intestinal mucosa of patients with ulcerative colitis in remission reveals lasting epithelial cell alterations[J]. Gut, 2013, 62(7): 967–976.

[24] Jayshree Mishra, Raj K Verma, Gianfranco Alpini, et al. Role of Janus kinase 3 in mucosal differentiation and predisposition to colitis.[J]. J Biol Chem, 2013, 288 (44): 31795-31806.

[25] 张天涵, 沈洪. 基于IL-6/JAK2/STAT3信号通路中药抗溃疡性结肠炎研究进展[J].环球中医药, 2019, 12(10): 1600-1605.

[26] Roberta Izzo, Gerolamo Bevivino, Giovanni Monteleone. Tofacitinib for the treatment of ulcerative colitis[J] .Expert Opin Investig Drugs, 2016, 25 (8): 991-997.

[27] Zhang Yi-fang, Han Dan-dan, Yu Shen, et al. Protective effect of iridoid glycosides of the leaves of syringa oblata Lindl. on dextran sulfate sodium-induced ulcerative colitis by inhibition of the TLR2/4/MyD88/NF-κB signaling pathway[J]. Biomed Res Int, 2020, 2020: 7650123.

[28] Seung Kak Shin, Jae Hee Cho, Eui Joo Kim, et al. Anti-inflammatory and anti-apoptotic effects of rosuvastatin by regulation of oxidative stress in a dextran sulfate sodium-induced colitis model[J]. World J Gastroenterol, 2017, 23 (25): 4559-4568.

[29] Xue Bing, Liu Xue-lei, Dong Wan-wei, et al. EGCG maintains Th1/Th2 balance and mitigates ulcerative colitis induced by dextran sulfate sodium through TLR4/MyD88/NF-κB signaling pathway in rats[J]. Can J Gastroenterol Hepatol, 2017, 2017: 3057268.

[30] Woo-Jeong Shon, Young-Kwan Lee, Ji H Shin, et al. Severity of DSS-induced colitis is reduced in Ido1-deficient mice with down-regulation of TLR-MyD88-NF-kB transcriptional networks[J]. Scientific Reports, 2015, 5: 17305.

[31] 田敏秀, 彭帅, 沈磊. IDO1抑制剂对葡聚糖硫酸钠诱导小鼠溃疡性结肠炎的作用及其对MyD88信号通路的影响[J].胃肠病学和肝病学杂志, 2020, 29(06): 677-681.

[32] Fu Xiao-xia, Sun Fei, Wang Fa-xi, et al. Aloperine protects mice against DSS-induced colitis by PP2A-mediated PI3K/Akt/mTOR signaling suppression[J]. Mediators Inflamm, 2017, 2017: 5706152.

[33] Li Ning, Sun Wen-jing, Zhou Xin, et al. Dihydroartemisinin protects against dextran sulfate sodium-induced colitis in mice through inhibiting the PI3K/AKT and NF-κB signaling pathways[J]. Biomed Res Int, 2019, 2019: 1415809.

[34] Haroon Khan, Antoni Sureda, Tarun Belwal, et al. Polyphenols in the treatment of autoimmune diseases[J] .Autoimmun Rev, 2019, 18 (7): 647-657.

[35] 陈志平, 王雯, 张志坚, 等. 丹参多酚酸盐治疗溃疡性结肠炎的效果观察[J].临床合理用药杂志, 2019, 12(35): 55-56.

[36] Peng Ke-yu, Gu Jun-fei, Su Shu-lan, et al. Salvia miltiorrhiza stems and leaves total phenolic acids combination with tanshinone protect against DSS-induced ulcerative colitis through inhibiting TLR4/PI3K/AKT/mTOR signaling pathway in mice [J]. J Ethnopharmacol, 2020, 264: 113052.

[37] Hyemee Kim, Nivedita Banerjee, Ryan C Barnes, et al. Mango polyphenolics reduce inflammation in intestinal colitis-involvement of the miR-126/PI3K/AKT/mTOR axis in vitro and in vivo [J]. Mol Carcinog, 2017, 56 (1): 197-207.

[38] Tomoko Hyoda, Takayuki Tsujioka, Nakahara Takako, et al. Rigosertib induces cell death of a myelodysplastic syndrome-derived cell line by DNA damage-induced G2/M arrest[J]. Cancer Sci, 2015, 106 (3): 287-293.

[39] 黄晓丽, 甘华田, 郝清华. 磷脂酰肌醇3激酶/Akt在溃疡性结肠炎中的表达[J]. 现代预防医学, 2008, (09): 1733-1735.

[40] Farzad Rahmani, Fereshteh Asgharzadeh, Amir Avan, et al. Rigosertib potently protects against colitis-associated intestinal fibrosis and inflammation by regulating PI3K/AKT and NF-κB signaling pathways [J]. Life Sci, 2020, 249: 117470.

[41] Jakob B Seidelin, Jacob T Bjerrum, Mehmet Coskun, et al. IL-33 is upregulated in colonocytes of ulcerative colitis [J]. Immunol Lett, 2010, 128 (1): 80-85.

[42] Luca Pastorelli, Rekha R Garg, Sharon B Hoang, et al. Epithelial-derived IL-33 and its receptor ST2 are dysregulated in ulcerative colitis and in experimental Th1/Th2 driven enteritis [J]. Proc Natl Acad Sci USA, 2010, 107 (17): 8017-8022.

[43] Mamdouh A K Sedhom, Mélanie Pichery, Jenna R Murdoch, et al. Neutralisation of the interleukin-33/ST2 pathway ameliorates experimental colitis through enhancement of mucosal healing in mice [J]. Gut, 2013, 62 (12): 1714-1723.

[44] 梁桐尔, 刘杨洋, 王烜. 基于IL-33/ST2信号通路的茯苓多糖调控溃疡性结肠炎大鼠肥大细胞活化的机制研究[J].中国免疫学杂志, 2020, 36(11): 1324-1329, 1337.

[45] Ashish Tyagi, Arun K Sharma, Chendil Damodaran. A review on notch signaling and colorectal cancer[J].Cells, 2020, 9 (6): 1549.

[46] Zhao Ya-xing, Luan Hao-fan, Gao Hui, et al. Gegen Qinlian decoction maintains colonic mucosal homeostasis in acute/chronic ulcerative colitis via bidirectionally modulating dysregulated Notch signaling [J]. Phytomedicine, 2020, 68: 153182.

[47] 惠毅, 闫曙光, 李京涛, 等. 小檗碱与6-姜烯酚配伍对溃疡性结肠炎小鼠结肠上皮细胞Notch信号通路的影响[J].中草药, 2019, 50(13): 3147-3154.

[48] Ran Hori, Kozo Yamaguchi, Hidetaka Sato, et al. The discovery and characterization of K-563, a novel inhibitor of the Keap1/Nrf2 pathway produced by Streptomyces sp [J]. Cancer Med, 2019, 8 (3): 1157-1168.

[49] Liu Yao-wu, Liu Xiao-li, Kong Li, et al. Neuroprotection of quercetin on central neurons against chronic high glucose through enhancement of Nrf2/ARE/glyoxalase-1 pathway mediated by phosphorylation regulation[J]. Biomed Pharmacother, 2019, 109: 2145-2154.

[50] Zhou Yan-ping, Jiang Zhong-liang, Lu Hai-ying, et al. Recent advances of natural polyphenols activators for Keap1-Nrf2 signaling pathway[J]. Chem Biodivers, 2019, 16 (11): e1900400.

[51] Han Dan-dan, Gu Xiao-long, Gao Jian, et al. Chlorogenic acid promotes the Nrf2/HO-1 anti-oxidative pathway by activating p21 to resist dexamethasone-induced apoptosis in osteoblastic cells [J]. Free Radic Biol Med, 2019, 137: 1-12.

[52] Tin Oo Khor, Huang Mou-Tuan, Ki Han Kwon, et al. Nrf2- deficient mice have an increased susceptibility to dextran sulfate sodium-induced colitis [J]. Cancer Res, 2006, 66 (24): 11580-11584.

[53] 马涛. Nrf-2在溃疡性结肠炎病灶组织中的表达及其与抗氧化酶含量、组织损伤程度的相关性[J].海南医学院学报, 2017, 23(13): 1783-1786.

[54] 方静, 陈江, 彭君伟, 等. 基于Nrf2通路探讨薏苡附子败酱散治疗溃疡性结肠炎的作用机制[J].中国实验方剂学杂志, 2018, 24(13): 85-92.

[55] Xu Li-li, Liu Tian, Wang Lei, et al. 3-(1H-Benzo[]imidazol-6-yl)-5-(4-fluorophenyl)-1,2,4-oxadiazole (DDO7232), a novel potent Nrf2/ARE inducer, ameliorates DSS-induced murine colitis and protects NCM460 cells against oxidative stress via ERK1/2 phosphorylation [J]. Oxid Med Cell Longev, 2018, 2018: 3271617.

[56] 刘鑫, 吴亚俐, 刘凯丽, 等. 白藜芦醇对小鼠溃疡性结肠炎的影响[J].中国应用生理学杂志, 2019, 35(05): 447-453.

[57] B O Ajayi, I A Adedara, E O Farombi. Protective mechanisms of 6-gingerol in dextran sulfate sodium-induced chronic ulcerative colitis in mice [J] .Hum Exp Toxicol, 2018, 37 (10): 1054-1068.

[58] 唐苗, 卢倩, 刘衡, 等. 溃疡性结肠炎相关信号通路的研究进展[J].中国药理学通报, 2018, 34(12): 1642-1647.

[59] William J Sandborn, Laurent Peyrin-Biroulet, Zhang Jin-kun, et al. Efficacy and Safety of Etrasimod in a Phase 2 Randomized Trial of Patients With Ulcerative Colitis [J].Gastroenterology, 2020, 158 (3): 550-561.

药物治疗溃疡性结肠炎的信号通路研究进展

Research Progress of Signal Pathways in Drug Treatment of Ulcerative Colitis

PDF (PC)

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 15

编辑推荐

Metrics

[1]	张健美, 张丹参. 溃疡性结肠炎中西治疗的研究进展#br#[J]. 神经药理学报, 2020, 10(5): 43-47.
[2]	杨旭华, 杜爽, 沈丽霞, 郝军荣. 阿尔茨海默病的药物治疗研究进展[J]. 神经药理学报, 2020, 10(3): 47-53.
[3]	夏小雯, 宋春红, 乔明琦, 等. 经前烦躁障碍症发生机制研究进展[J]. 神经药理学报, 2019, 9(6): 36-40.
[4]	张佳琳，李元元，杨文亮，刘富甲，田子夏，谢欣梅，庞晓斌. 黄芪甲苷基于PI3K/Akt/Bcl-2 信号通路对PC12 细胞OGD/R 损伤的保护机制研究[J]. 神经药理学报, 2017, 7(5): 1-9.
[5]	张丽娜，张欣，薛娟，张丹参. 中药对中枢神经退行性疾病信号通路影响的研究进展[J]. 神经药理学报, 2017, 7(3): 33-42.
[6]	龙森，陈嘉烨，韩峰. 童年孤独症发病机制及药物治疗进展[J]. 神经药理学报, 2016, 6(6): 55-64.
[7]	宋晓敏，张丹参，庄忠宝，张海威，苏晓梅，赵凯燕，张力. 噁唑酮与三硝基苯磺酸联用诱导小鼠慢性溃疡性结肠炎模型[J]. 神经药理学报, 2016, 6(3): 17-23.
[8]	张丹参，梅艳飞，宋晓敏，庄忠宝. 大鼠溃疡性结肠炎模型的构建及大黄结肠靶向微丸的干预作用[J]. 神经药理学报, 2016, 6(2): 14-19.
[9]	王欢欢, 薛茜, 邹玉安. 内源性抗氧化应激机制在缺血预处理与缺血再灌注损伤中的研究进展[J]. 神经药理学报, 2016, 6(2): 46-52.
[10]	宋晓敏, 庄忠宝, 张海威, 张力. 性别对两种溃疡性结肠炎模型的影响[J]. 神经药理学报, 2015, 5(6): 11-20.
[11]	张丹参，王倩，田慧，薛贵平，张力. 大黄栓制剂对两种溃疡性结肠炎模型小鼠的作用研究[J]. 神经药理学报, 2015, 5(1): 19-37.
[12]	李牧函，余冰颖，刘屏. 胞外信号调控激酶（ERK）信号通路与抑郁症[J]. 神经药理学报, 2015, 5(1): 38-44.
[13]	王倩, 田慧, 刘靓靓, 钟明, 梅艳飞, 张力. 溃疡性结肠炎模型的构建及其炎症反应机制研究[J]. 神经药理学报, 2014, 4(5): 15-23.
[14]	柳江枫, 杨宝学. RGMb/DRAGON介导的信号通路及其研究进展[J]. 神经药理学报, 2014, 4(2): 46-54.
[15]	刘婷婷, 王文. Eph/ephrin信号通路与脑神经发生的综述[J]. 神经药理学报, 2014, 4(1): 25-28.